Literature DB >> 9151113

Localization of vitronectin in the normal and atherosclerotic human vessel wall.

B E van Aken1, D Seiffert, T Thinnes, D J Loskutoff.   

Abstract

Vitronectin (Vn) regulates proteolytic enzyme systems, as well as cell migration and tissue remodelling. These processes have been implicated in the pathogenesis of atherosclerosis. In this study, the distribution of Vn antigen in apparently normal and atherosclerotic human blood vessels was evaluated. Normal and diseased vessels showed Vn immunostaining in the lamina elastica interna and externa, and in strand-like structures in the adventitia. In most of these instances, the Vn antigen appeared to be located in the proximity of elastin. In pulmonary arteries, Vn staining was additionally detected in the media. The intima was devoid of Vn antigen in all vessels studied. In general, there was increased deposition of Vn antigen in the atherosclerotic arteries. In particular, strong Vn staining was apparent in amorphous material adjacent to cholesterol clefts and in acellular fibrous tissue, in plaques present in the carotic artery and aorta. Collagen layers and fresh fibrin depositions were devoid of Vn antigen. In spite of the abundance of Vn immunostaining throughout the normal and diseased vessel wall, the Vn transcript was not detectably by in situ hybridization. These results indicate that Vn is a constituent of the normal vessel wall and raise the possibility that increased local deposition of Vn may be related to the development of atherosclerotic vascular disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151113     DOI: 10.1007/s004180050116

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  15 in total

1.  Vitronectin from brain pericytes promotes adult forebrain neurogenesis by stimulating CNTF.

Authors:  Cuihong Jia; Matthew P Keasey; Hannah M Malone; Chiharu Lovins; Richard R Sante; Vlad Razskazovskiy; Theo Hagg
Journal:  Exp Neurol       Date:  2018-11-06       Impact factor: 5.330

2.  Discovery and characterization of potential prognostic biomarkers for dengue hemorrhagic fever.

Authors:  B Katherine Poole-Smith; Alexa Gilbert; Andrea L Gonzalez; Manuela Beltran; Kay M Tomashek; Brian J Ward; Elizabeth A Hunsperger; Momar Ndao
Journal:  Am J Trop Med Hyg       Date:  2014-10-27       Impact factor: 2.345

3.  Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.

Authors:  P Sen; A A Komissarov; G Florova; S Idell; U R Pendurthi; L Vijaya Mohan Rao
Journal:  J Thromb Haemost       Date:  2011-03       Impact factor: 5.824

4.  Integrin-αvβ3 regulates thrombopoietin-mediated maintenance of hematopoietic stem cells.

Authors:  Terumasa Umemoto; Masayuki Yamato; Jun Ishihara; Yoshiko Shiratsuchi; Mika Utsumi; Yohei Morita; Hiroko Tsukui; Masao Terasawa; Takehiko Shibata; Kohji Nishida; Yoshiro Kobayashi; Brian G Petrich; Hiromitsu Nakauchi; Koji Eto; Teruo Okano
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

5.  Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1.

Authors:  B Titz; S Dietrich; T Sadowski; C Beck; A Petersen; R Sedlacek
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

6.  Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease.

Authors:  Hakan Ekmekci; Huseyin Sonmez; Ozlem B Ekmekci; Zeynep Ozturk; Nergiz Domanic; Emine Kokoglu
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

7.  Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.

Authors:  Yan Ji; Zhen Weng; Philip Fish; Neha Goyal; Mao Luo; Samantha P Myears; Tammy L Strawn; Bysani Chandrasekar; Jianbo Wu; William P Fay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-22       Impact factor: 8.311

8.  Prognostic utility of serum vitronectin levels in acute myocardial infarction.

Authors:  S Aslan; B Ikitimur; H A Cakmak; B Karadag; E Y Tufekcioglu; H Ekmekci; H Yuksel
Journal:  Herz       Date:  2014-05-15       Impact factor: 1.443

9.  Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin.

Authors:  M Luo; Y Ji; Y Luo; R Li; W P Fay; J Wu
Journal:  J Thromb Haemost       Date:  2017-11-08       Impact factor: 5.824

10.  Interaction of late apoptotic and necrotic cells with vitronectin.

Authors:  Ondrej Stepanek; Tomas Brdicka; Pavla Angelisova; Ondrej Horvath; Jiri Spicka; Petr Stockbauer; Petr Man; Vaclav Horejsi
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.